MARKET

SAVA

SAVA

Cassava Sciences
NASDAQ
2.130
-0.040
-1.84%
After Hours: 2.120 -0.01 -0.47% 19:48 02/20 EST
OPEN
2.160
PREV CLOSE
2.170
HIGH
2.170
LOW
2.080
VOLUME
758.42K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
1.150
MARKET CAP
102.90M
P/E (TTM)
-0.9692
1D
5D
1M
3M
1Y
5Y
1D
Trump Trade: Warner sale triggers probe on theater, film release impact
TipRanks · 2d ago
Cassava Sciences DOJ Inquiry Closed, Legal Overhang Eased
TipRanks · 2d ago
BUZZ-Cassava Sciences rises after US DOJ closes probe into company
Reuters · 2d ago
Cassava Sciences says US DOJ has closed investigation into company
Reuters · 2d ago
Cassava says DoJ has ended probe into research misconduct
Seeking Alpha · 2d ago
Cassava Sciences announces closure of DOJ investigation
TipRanks · 2d ago
Cassava Sciences Says U.S. DOJ Fraud Section Closes Its Inquiry Into The Company Regarding Allegations Of Research Misconduct
Benzinga · 2d ago
Cassava Sciences Says DOJ Closes Investigation
Reuters · 2d ago
More
About SAVA
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Webull offers Cassava Sciences Inc stock information, including NASDAQ: SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAVA stock methods without spending real money on the virtual paper trading platform.